InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016786 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-07 2023-03-03 APVO Kwon SoYoung SVP, GC, BD, Corp Affairs M - OptEx — +3,666 5,499 +200% —
D 2023-03-07 2023-03-03 APVO Kwon SoYoung SVP, GC, BD, Corp Affairs M - OptEx $0.00 -3,666 7,334 -33% $0
DM 2023-03-07 2023-03-03 APVO Kwon SoYoung SVP, GC, BD, Corp Affairs A - Grant $0.00 +22.0K 11.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-03 M A 3,666 — 5,499 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Derivative Restricted Stock Unit 2023-03-03 M D 3,666 $0.00 7,334 D — · — to — 3,666 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
3 Derivative Restricted Stock Unit 2023-03-03 A A 11,000 $0.00 11,000 D — · — to — 11,000 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) The RSUs vest in three approximately equal annual installments beginning on March 2, 2024.
4 Derivative Stock Option (right to buy) 2023-03-03 A A 11,000 $0.00 11,000 D $2.15 · — to 2033-03-02 11,000 Common Stock (F4) The option vests in three approximately equal annual installments beginning on March 2, 2024.